MDMA is in the slightly odd state of being both a Class A/Schedule 1 drug and an official breakthrough therapy. Technically, this doesn’t make sense, as a criterion for schedule 1 is having no therapeutic value. As the studies continue, the law, theoretically, will have to change.
Alexander M. Combstrong